RSG
71
3
USB
55
-6
SLB
55
2
GOOG
50
-3
HCP
66
8
CMG
72
5
VRSN
53
-4
EMN
60
4
ES
34
3
CINF
53
2
NEE
50
-5
PVH
62
5
STI
14
-17
PAYX
53
2
PFE
23
7
EFX
38
2
DD
63
3
CRM
67
2
ISRG
74
-2
ADT
53
3
RSG
71
3
USB
55
-6
SLB
55
2
GOOG
50
-3
HCP
66
8
CMG
72
5
VRSN
53
-4
EMN
60
4
ES
34
3
CINF
53
2
NEE
50
-5
PVH
62
5
STI
14
-17
PAYX
53
2
PFE
23
7
EFX
38
2
DD
63
3
CRM
67
2
ISRG
74
-2
ADT
53
3
Financhill
Back

PTC Therapeutics 10K Form

Sell
37

PTCT
PTC Therapeutics

Last Price:
43.09
Seasonality Move:
23.53%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-04-25 10Q PTCT/PTC Therapeutics Quarterly
2023-10-26 10Q PTCT/PTC Therapeutics Quarterly
2023-08-03 10Q PTCT/PTC Therapeutics Quarterly
2023-04-27 10Q PTCT/PTC Therapeutics Quarterly
2022-10-27 10Q PTCT/PTC Therapeutics Quarterly
2022-08-04 10Q PTCT/PTC Therapeutics Quarterly

Receive PTCT News And Ratings

See the #1 stock for the next 7 days that we like better than PTCT

PTCT Financial Statistics

Sales & Book Value

Annual Sales: $937.82M
Cash Flow: $-87.77M
Price / Cash Flow: 0
Annual Sales: $-13.70
Price / Book: 0

Profitability

EPS (TTM): -5.94000
Net Income (TTM): $-453.2M
Gross Margin: $872.34M
Return on Equity: 0%
Return on Assets: -26.04%

PTC Therapeutics Earnings Forecast

Key PTC Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 11 years for PTCT is 93.02%.
  • The Selling, General & Administrative Expenses for PTCT have been equal to 35.46% of Gross Profit Margin.
  • The Research & Development expenses have been 71.08% of Revenue.
  • The Interest Expense is -20.62% of Operating Income.
  • The Net Earning history of PTCT is -66.81% of Total Revenues.
  • Per Share Earnings over the last 13 years have been positive in 4 years.

PTC Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: PTCT
CUSIP: 69366J
Website: ptcbio.com

Debt

Debt-to-Equity Ratio: -0.27
Current Ratio: 2.1
Quick Ratio: 1.99

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PTCT Technical Analysis vs Fundamental Analysis

Sell
37
PTC Therapeutics (PTCT) is a Sell

Is PTC Therapeutics a Buy or a Sell?

  • PTC Therapeutics stock is rated a Sell
    The current PTC Therapeutics [PTCT] share price is $43.23. The Score for PTCT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.